Arcflex sheath for heart valve replacement
Part of Heart & circulation clinical trials.
This study tests a new tube, the Arcflex sheath, used during a procedure to replace a narrowed heart valve in the groin. It may help doctors place the new valve more safely and effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your heart doctor says you need a heart valve replacement (TAVR).
- You have symptoms like breathlessness or tiredness with everyday activities (NYHA class II or higher).
- The doctors check that your leg arteries are suitable for the procedure through the groin.
- You are expected to live at least another year.
- You want to take part, understand the study, and agree to follow-ups.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a less invasive heart valve procedure that places a new valve through a catheter, to treat severe leakage of the aortic valve. It may help people who have symptoms or heart enlargement and who are at higher risk for open-heart surgery.
This trial tests a new delivery system (VitaFlow Liberty Flex) for placing a replacement aortic valve in people with severe aortic stenosis. It is designed for patients whose heart anatomy (a steep angle between the heart and aorta) makes the procedure more challenging.
This trial studies whether a new through-the-blood-vessel heart valve (TAVR) is safe and works well for people with severe aortic stenosis who are too risky for traditional surgery. If you qualify, you would be closely followed to check your symptoms and valve function over time.
This trial is testing a new, less invasive way to replace a narrowed aortic valve using a special device. The goal is to help improve blood flow and reduce symptoms like chest pain and shortness of breath.
This study tests a new valve replacement for people with severe aortic regurgitation (leaky heart valve) who are not good candidates for open surgery. The valve is put in through a small tube in the leg, which may be less risky for high-risk patients.
This trial compares two newer types of replacement heart valves (SAPIEN 3 Ultra Resilia and Evolut FX) to see which one works better for people with severe aortic stenosis, a condition where the heart's main valve becomes narrow. If you join, you'll be randomly assigned to receive one of the two valves during your TAVI procedure.
Hear when a new Valve Disease, Aortic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.